Invesco Dorsey Wright Healthcare Momentum ETF PTH
58.51 USD -1.34 (-2.24%)
Nov 12, 2026, 12:59 PM EST
57.61 Day range 58.97
46.09 52-week range 64.10
- YTD
- +17.73%
- 1 year
- +20.02%
News
benzinga.com Moderna Advances Ebola Vaccine Into Human Testing Moderna starts Phase 1 trials for Ebola vaccine mRNA-1469. See premarket MRNA stock reaction, analyst updates, and ETF exposure.
benzinga.com Judge Hands Natera 30% Ongoing Royalty In MRD Patent Battle Natera rises after a Delaware court grants a 30% ongoing royalty in its MRD patent battle with ArcherDx and Invitae.
benzinga.com FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer FDA approves Guardant Health's blood test to help identify metastatic colorectal cancer patients eligible for targeted treatment.
benzinga.com Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs The FDA's warnings to Eli Lilly, Novo Nordisk and Hims & Hers spotlight risks for ETFs tied to the weight-loss drug boom.
benzinga.com US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget A federal judge halted NIH's plan to cap indirect grant costs at 15%, citing potential harm to research. A hearing is set for February 21.
benzinga.com FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen' FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency.
benzinga.com Hims & Hers Health Sees Major Growth Opportunity In Booming Weight Loss Market, Says Analyst Needham analyst initiates coverage on Hims & Hers Health, Inc. with a Buy rating and $24 price target. Anticipates positive impact from GLP-1 market entry and strong growth potential.
benzinga.com Is Reddit Favorite BioNano Genomics About To Nosedive? BioNano Genomics (NASDAQ: BNGO) is testing an important support at the $5 level. If this support breaks, shares could make a rapid and large move lower. There’s an old saying on Wall Street that…
benzinga.com 3 Health Care ETFs Where Components Are Enduring Downgrades After setting scintillating paces earlier this thanks to the race to develop a coronavirus vaccine, some health care exchange-traded funds are languishing.
benzinga.com 3 ETFs To Play Gilead's $21B Immunomedics Takeover Biotechnology mergers and acquisitions appear to be back in a big way with news that Gilead Sciences (NASDAQ: GILD) is acquiring Immunom
benzinga.com Spicing Up The Health Care Trade - benzinga.com Investors Are Flocking To This New ETF
benzinga.com Riding The ETF Momentum Into 2016 - benzinga.com The Final Four: New ETF Focuses On Four Momentum Funds
- benzinga.com Two Sub-$100M ETFs That Have Outperformed Larger Rivals
- benzinga.com Amgen Acquires KAI Pharmaceuticals
- benzinga.com Cooper Companies Earnings Preview: Double-Digit Revenue Growth Expected
- benzinga.com Analogic Earnings Preview: EPS Expected to Double
- benzinga.com Twelve Health Care ETFs Trading Near 52-Week Highs